20 to 30% of patients treated with IFN-α even develop the full symptomatology of a major depression, with symptoms such as sadness, loss of energy, interest, and joy, anxiety, insomnia, lack of appetite, impaired concentration, suicidal ideation or suicide attempts. This evidence concerns the gene IFNA1 and major depressive disorder.